Changeflow GovPing Pharma & Drug Safety Chitosan-based beads, preparation, compositions...
Routine Notice Added Final

Chitosan-based beads, preparation, compositions and uses thereof

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published April 7th, 2026
Detected April 7th, 2026
Email

Summary

KIOMED PHARMA has been granted USPTO Patent US12595342B2 for chitosan-based beads comprising a hydrogel matrix with carboxyalkyl chitosan. The patent contains 41 claims covering the composition, preparation methods, and pharmaceutical applications of the technology.

What changed

KIOMED PHARMA received USPTO Patent US12595342B2 (Kind B2) on April 7, 2026, covering chitosan-based beads and compositions. The 41-claim patent describes carboxyalkyl chitosan hydrogels with glucosamine units crosslinked by covalent bonds for pharmaceutical applications. The patent application (No. 17790180) was filed on November 22, 2021.\n\nPharmaceutical manufacturers and biotech companies developing hydrogel-based drug delivery systems should be aware of this newly granted IP, as it may restrict freedom to operate in this specific technological space. The patent provides KIOMED PHARMA exclusive rights to manufacture and commercialize chitosan-based bead compositions in the United States.

What to do next

  1. Monitor for updates

Source document (simplified)

← USPTO Patent Grants

Chitosan-based beads, and preparation, compositions and uses thereof

Grant US12595342B2 Kind: B2 Apr 07, 2026

Assignee

KIOMED PHARMA

Inventors

Mickaël Chausson, Sandrine Emilia Gautier, Laurence Hermitte, Antoine Rabeux, Guillermo Rocasalbas

Abstract

The invention relates to beads and a composition comprising an aqueous phase comprising a plurality of beads, the beads comprising or consisting in a hydrogel matrix comprising at least one carboxyalkyl chitosan having glucosamine units, N-acetyl-glucosamine units and glucosamine units substituted with a carboxyalkyl group, the carboxyalkyl chitosan being crosslinked by covalent bonds between the carboxyalkyl chitosan chains and/or co-crosslinked by covalent bonds with one or more other polymers. The invention also relates to processes for their preparation and applications thereof.

CPC Classifications

C08L 5/08 A61K 31/722 A61K 9/0019 C08J 3/075

Filing Date

2021-11-22

Application No.

17790180

Claims

41

View original document →

Get daily alerts for ChangeBridge: Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12595342B2

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent examination IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.